KKR Takes Integer Holdings Private at $5.7 Billion in Medical Device Consolidation Play
All-cash deal strips out public equity from a cardiac rhythm and neuromodulation component maker as private capital tightens grip on med-tech infrastructure.
KKR agreed to acquire Integer Holdings Corporation in an all-cash transaction valuing the medical device component manufacturer at $5.7 billion including debt, removing the Texas-based supplier from public markets as buyout shops continue aggressive positioning in healthcare infrastructure. The deal, announced Wednesday, represents a 42% premium to Integer's thirty-day volume-weighted average share price and marks one of the larger healthcare take-privates since the Federal Reserve pivoted from its tightening cycle.
Integer manufactures components for cardiac rhythm management devices, neuromodulation systems, and advanced surgical tools—selling into Boston Scientific, Medtronic, Abbott, and other large-cap med-tech names. The company reported $1.52 billion in revenue for the twelve months ending September 2024, with operating margins in the mid-teens. KKR is acquiring stable cash flow and entrenched relationships inside a regulatory-moated sector where switching costs run high and product cycles stretch across years. The transaction includes Integer's entire portfolio, including its Greatbatch Medical and Lake Region Medical divisions, both legacy assets with deep manufacturing scale.
The move reflects continued private equity appetite for non-branded healthcare infrastructure plays—companies that sit one layer below the device OEMs and benefit from secular procedure volume growth without bearing the full weight of FDA approval timelines or reimbursement risk. KKR has deployed over $20 billion in healthcare since 2020, including takes on Envision Healthcare, Cotiviti, and a minority stake in Syneos Health before its later sale. Integer fits the pattern: defensible margins, long-term contracts, and limited exposure to consumer-facing brand risk. The transaction also removes a public equity float that had traded sideways for eighteen months as growth investors rotated out of mid-cap industrials into AI and semiconductors.
Operators and allocators should watch for two follow-on developments. First, whether KKR consolidates Integer with other portfolio assets in adjacent supply chain nodes—particularly surgical tool OEMs or battery technology platforms—within the next twelve to eighteen months. Second, how Integer's customer base responds to the ownership change, especially regarding supply assurance and capital investment in next-generation manufacturing capacity. Boston Scientific and Medtronic both source heavily from Integer; any pause in capex or delivery timelines could create short-term volatility in their component procurement.
The deal is expected to close mid-2025, subject to shareholder approval and regulatory clearance. Integer's management team remains in place, a signal KKR intends operational continuity rather than restructuring. The financing package has not been disclosed, but given current leverage multiples in healthcare services trades, expect debt in the 5.0x to 5.5x EBITDA range, with the rest in equity from KKR's latest flagship fund.
The takeaway
KKR strips $5.7B medical device supplier Integer Holdings from public markets, securing cash flow and OEM relationships in a regulatory-moated sector.
Editorial & Disclosure Notice: This article was written with artificial intelligence from public sources and is published without individual human review. Artificial intelligence and other digital tools are also used for research, analysis, editing, formatting, and production. Errors, omissions, outdated information, or inaccuracies may occur. References to companies, brands, products, services, organizations, or individuals are for informational and editorial purposes and do not imply endorsement, sponsorship, affiliation, partnership, or approval unless expressly stated. All trademarks and other intellectual property remain the property of their respective owners. Opinions, analysis, estimates, and commentary are informational only and should not be construed as financial, investment, legal, tax, medical, procurement, or other professional advice. Information may be corrected, clarified, or updated after publication. Corrections or removal requests: jenny@pops4.com.
Want the 60-second program for your specific event?
Enter your event and email — we build it and send the branded proposal before lunch. No obligation.
The branded-identity layer Chiefs of Staff and heritage CMOs route through — your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.
200+authorized brands
70,000products · virtual proof on each
9 deskspublishing daily
1997one house, since
70,000 SKUs · virtual proof in 60 seconds · no platform fee · blind-shipped · ASI #217876
Your next customer won't visit your website. Their AI will.
AI assistants have quietly taken over the first step of buying — they answer from catalogs they can read and shortlist whoever can actually ship. Two questions now decide whether you exist to that buyer: can a machine read your catalog, and can you fulfill the order. Most brands fail one or both and never find out why the orders went elsewhere. The winners of this shift aren't the loudest. They're the most readable. Build for the machine that's about to do the shopping.
Built by the craft floor — apparel, media, packaging, and secure print.
This trade runs on hands, not desks. Imprint manufacturing & Komori heritage press through approved vendors · Canon high-speed secure-media operations is a craft floor — genuine Six Sigma discipline applied to ink, thread, foil, and registration, where a hundredth of an inch is the difference between a brand that reads serious and one that reads cheap. POPS4 is built by exactly those operators: independent, boots-on-the-ground engineers who carry their own book, read a client in microseconds, and put their name on every run. Beyond our own Virginia Beach floor, we work with a vetted network of craft manufacturers across the US — each meeting the highest excellence in QC standards in the industry, each a specialist in its own discipline — so apparel, hard-goods imprinting, media manufacturing, packaging, and secure printing all go to the bench built for them, coordinated from one accountable hub. Short-run from twenty-five units, volume to five hundred thousand. Two hundred authorized national brands, seventy thousand SKUs with virtual proofing on every one. Art archived for instant reorders. Net-thirty corporate terms, NDA-standard white-label — your name on the work, or none at all.
Strategy, positioning, identity, creative, and messaging — wired into an AI system that publishes and distributes on its own. Nine editorial desks generate the authority, the production house ships the physical proof, and the attribution layer tells you which post sold which SKU. What you get is an operating layer — content, catalog, and order path under one roof — that keeps working whether or not you are in the room. Built for principals who would rather own the machine than rent the agency.
Named-account programs — one desk, quiet delivery, NDA-standard.
One point of contact who already knows the file, so nothing restarts from zero between engagements. The work ships blind, under NDA, with your name on it or none at all. Built for single-family offices, heritage-house CMOs, sports-ownership groups, and the agencies that white-label our production. The relationship is the product; the merch is the proof of it.
SFO · Chief of Staff desk. Principal household, properties, aircraft, yacht, calendar, philanthropy — one file.
Shop seventy thousand products. Virtual proof on every one. 24/7.
Drop your logo on any product and see the virtual proof before asking. Quote routes direct to the desk. MCP catalog for AI agents. Celeste for the fast conversation. Full self-service checkout in development.